POST EXPOSURE PROPHYLAXIS AGAINST HIV 1 BY CD4 IGG2
POST EXPOSURE PROPHYLAXIS AGAINST HIV 1 BY CD4 IGG2
批准号:
2545220
负责人:
PAUL J MADDON
金额:
$37.52万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-09-30 至 1998-09-29
关键词:
AIDS education /prevention AIDS therapy CD4 molecule HIV infections Macaca mulatta SCID mouse antiAIDS agent chimeric proteins human immunodeficiency virus 1 immunoconjugates immunoglobulin G monoclonal antibody neutralizing antibody nonhuman therapy evaluation pharmacokinetics recombinant virus simian immunodeficiency virus
中文摘要
在第一阶段的项目中,我们证明了一种新型的基于CD4的蛋白质,
CD4-IgG2具有优良的特性,可作为一种新型的
预防HIV-1感染的药物,以保护个人免受
环境中的感染,如垂直和职业接触
病毒。与HIV免疫球蛋白(HIVIG)相比,CD4-IgG2的主要优势
而针对该病毒的单抗是CD4-IgG2中和所有
HIV-1的菌株,包括病毒的初级分离株。在.期间
I期,我们证明了CD4-IgG2在体外中和a
由来自不同基因分支的28个主要HIV-1分离株组成的小组。
此外,CD4-IgG2中和了未稀释的病毒血浆中的HIV-1
体外试验。最后,我们证明了CD4-IgG2对人外周血淋巴细胞的保护作用。
保护SCID小鼠免受HIV-1初级分离株的感染。这是第一次
在动物身上对HIV-1初级分离株的保护作用
使用任何免疫治疗或抗逆转录病毒药物的模型。
在二期项目中,我们将继续开发CD4-IgG2。
首先,我们将扩大生产流程,生产一克
蛋白质。我们将测试CD4-IgG2与广泛性的组合
中和抗HIV-1单抗,协同抑制病毒。
将在两个新的HIV-1信封中分析组合
糖蛋白介导的膜融合实验及体外实验
用HIV-1原代分离株进行中和试验。然后我们将比较
CD4-IgG2单抗与最佳单抗的保护力比较
几种原代HIV-1联合攻击Hu-PBL-SCID小鼠的实验研究
被猿人免疫缺陷挑战的分离株和猕猴
含有HIV-1主要分离株gp120/gp41的病毒(SIV)。
一种安全有效的HIV-1预防性制剂的研制
是一项紧迫的公共卫生优先事项。第二阶段的总体目标
项目是确定CD4-IgG2或CD4-IgG2和
广谱中和单抗,可预防原发感染
在现有的最佳动物模型中分离出HIV-1病毒。如果成功,则
第二阶段项目将成为该阶段临床试验的基础
第三阶段。
拟议的商业应用:开发作为一种
预防HIV-1感染的药物。
英文摘要
In the Phase I project, we demonstrated that a novel CD4-based protein,
CD4-IgG2, has excellent properties for further development as a
prophylactic agent for HIV-1 infection, to protect individuals from
infection in settings such as vertical and occupational exposure to the
virus. The major advantage of CD4-IgG2 over HIV immune globulin (HIVIG)
and monoclonal antibodies to the virus is that CD4-IgG2 neutralizes all
stains of HIV-1, including primary isolates of the virus. During the
Phase I period, we demonstrated that CD4-IgG2 neutralized in vitro a
panel of 28 primary HIV-1 isolates from different genetic clades.
Moreover, CD4-IgG2 neutralized HIV-1 in undiluted viremic plasma in an
ex vivo assay. Finally, we demonstrated that CD4-IgG2 protects hu-PBL-
SCID mice from infection by primary HIV-1 isolates. This is the first
demonstration of protection against primary HIV-1 isolates in an animal
model using any immunotherapeutic or antiretroviral agent.
In the Phase II project, we will continue the development of CD4-IgG2.
First, we will scale-up the production process and generate one gram of
the protein. We will test combinations of CD4-IgG2 with broadly
neutralizing mAbs to HIV-1 for synergistic inhibition of the virus.
Combinations will be analyzed in both a novel HIV-1 envelope
glycoprotein-mediated membrane fusion assay and in an in vitro
neutralization assay using primary HIV-1 isolates. We will then compare
the protective ability of CD4-IgG2 alone versus the optimal CD4-IgG2-mAb
combination in hu-PBL-SCID mice challenged with several primary HIV-1
isolates, and macaques challenged with simian-human immunodeficiency
virus (SHIV) containing gp120/gp41 of a primary HIV-1 isolate.
The development of a safe and effective prophylactic agent against HIV-1
is an urgent public health priority. The overall goal of the Phase II
project is to determine whether CD4-IgG2, or combinations of CD4-IgG2 and
broadly neutralizing mAbs, can protect against infection by primary
isolates of HIV-1 in the best available animal models. If successful, the
Phase II project will form the basis of clinical trials during the Phase
III period.
PROPOSED COMMERCIAL APPLICATION: Development of a CD4-IgG2 as a
prophylactic agent against HIV-1 infection.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
CCR5 inhibitors that block HIV but not chemokines
-
批准号:6746752
-
项目类别:
-
资助金额:$30.36万
-
财政年份:2004
-
负责人:PAUL J MADDON
-
依托单位:
Development of Small-Molecule HIV Entry Inhibitors
-
批准号:6698946
-
项目类别:
-
资助金额:$89.94万
-
财政年份:2001
-
负责人:PAUL J MADDON
-
依托单位:
HIV Vaccine Design and Development Team
-
批准号:6374728
-
项目类别:
-
资助金额:$209.05万
-
财政年份:2000
-
负责人:PAUL J MADDON
-
依托单位:
HIV Vaccine Design and Development Team
-
批准号:6348770
-
项目类别:
-
资助金额:$197.43万
-
财政年份:2000
-
负责人:PAUL J MADDON
-
依托单位:
CLINICAL TRIALS OF CD4 IGG2 AND HUMAB COMBINATIONS
-
批准号:2887738
-
项目类别:
-
资助金额:$54.6万
-
财政年份:1998
-
负责人:PAUL J MADDON
-
依托单位:
CLINICAL TRIALS OF CD4 IGG2 AND HUMAB COMBINATIONS
-
批准号:2643926
-
项目类别:
-
资助金额:$54.6万
-
财政年份:1998
-
负责人:PAUL J MADDON
-
依托单位:
CLINICAL TRIALS OF CD4 IGG2 AND HUMAB COMBINATIONS
-
批准号:6373836
-
项目类别:
-
资助金额:$54.6万
-
财政年份:1998
-
负责人:PAUL J MADDON
-
依托单位:
CLINICAL TRIALS OF CD4 IGG2 AND HUMAB COMBINATIONS
-
批准号:6510836
-
项目类别:
-
资助金额:$54.6万
-
财政年份:1998
-
负责人:PAUL J MADDON
-
依托单位:
CLINICAL TRIALS OF CD4 IGG2 AND HUMAB COMBINATIONS
-
批准号:6170605
-
项目类别:
-
资助金额:$54.6万
-
财政年份:1998
-
负责人:PAUL J MADDON
-
依托单位:
DEVELOPMENT OF ANTICO RECEPTOR MABS FOR HIV THERAPY
-
批准号:2793411
-
项目类别:
-
资助金额:$52.06万
-
财政年份:1996
-
负责人:PAUL J MADDON
-
依托单位:
DEVELOPMENT OF ANTICO RECEPTOR MABS FOR HIV THERAPY
-
批准号:6170001
-
项目类别:
-
资助金额:$59.45万
-
财政年份:1996
-
负责人:PAUL J MADDON
-
依托单位:
DEVELOPMENT OF ANTICO RECEPTOR MABS FOR HIV THERAPY
-
批准号:6373597
-
项目类别:
-
资助金额:$81.34万
-
财政年份:1996
-
负责人:PAUL J MADDON
-
依托单位:
POST EXPOSURE PROPHYLAXIS AGAINST HIV 1 BY CD4 IGG2
-
批准号:2004162
-
项目类别:
-
资助金额:$37.48万
-
财政年份:1996
-
负责人:PAUL J MADDON
-
依托单位:
POSTEXPOSURE PROPHYLAXIS AGAINST HIV 1 BY CD4 IGG2
-
批准号:2073306
-
项目类别:
-
资助金额:$9.98万
-
财政年份:1995
-
负责人:PAUL J MADDON
-
依托单位:
RAPID FLUOROMETRIC ASSAY OF HIV-INDUCED CELL FUSION
-
批准号:2067703
-
项目类别:
-
资助金额:$19.64万
-
财政年份:1992
-
负责人:PAUL J MADDON
-
依托单位:
RAPID FLUOROMETRIC ASSAY OF HIV-INDUCED CELL FUSION
-
批准号:3489609
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1992
-
负责人:PAUL J MADDON
-
依托单位:
RAPID FLUOROMETRIC ASSAY OF HIV-INDUCED CELL FUSION
-
批准号:2067704
-
项目类别:
-
资助金额:$26.75万
-
财政年份:1992
-
负责人:PAUL J MADDON
-
依托单位:
HIGH-LEVEL EXPRESSION OF HIV GP120 IN MAMMALIAN CELLS
-
批准号:2066683
-
项目类别:
-
资助金额:$21.21万
-
财政年份:1991
-
负责人:PAUL J MADDON
-
依托单位:
HIGH-LEVEL EXPRESSION OF HIV GP120 IN MAMMALIAN CELLS
-
批准号:2066684
-
项目类别:
-
资助金额:$28.78万
-
财政年份:1991
-
负责人:PAUL J MADDON
-
依托单位:
HIGH-LEVEL EXPRESSION OF HIV GP120 IN MAMMALIAN CELLS
-
批准号:3489513
-
项目类别:
-
资助金额:$4.97万
-
财政年份:1991
-
负责人:PAUL J MADDON
-
依托单位:
海外基金